NF-kappaB inhibition in dendritic cells pre-treated with sulforaphane-conjugates induces immunotolerance
Camila Leiva‐Castro, Ana Maria Múnera‐Rodríguez, Macarena Martínez‐Bailén, Ana Teresa Carmona, Soledad López-Enríquez, Francisca Palomares
This study shows SFN-glycoconjugates reduce inflammation in dendritic cells by targeting the NF-kappaB pathway, inducing immunotolerance better than NF-kappaB inhibition alone.
British Journal of Pharmacology · Jun 18, 2025Peer-reviewedBiochemistry